Cadrenal Therapeutics (CVKD) Earnings Date & Reports

Cadrenal Therapeutics Inc is a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and thrombotic conditions... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CVKD is expected to report earnings to rise 35.58% to -140 cents per share on August 06

Cadrenal Therapeutics CVKD Stock Earnings Reports

Q2'26

Est.

$-1.41

Q1'26

Beat

by $0.31

Q4'25

Beat

by $0.05

Q3'25

Beat

by $0.08

Q2'25

Missed

by $0.61

The last earnings report on May 07 showed earnings per share of -103 cents, beating the estimate of -135 cents. With 48.65K shares outstanding, the current market capitalization sits at 12.16M.

View a ticker or compare two or three

Compare

CVKD

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for CVKD